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ABSTRACT: It has been suggested that some pigments would have antioxidant
properties and that their presence in dietary constituents would contribute to
reduce the risk of oxidative stress–correlated diseases. Among others, inflam-
matory response depends on redox status and may implicate oxidative stress.
Vascular endothelial cells are a direct target of oxidative stress in inflamma-
tion. We have tested the impact of the free radical scavenger and antioxidant
properties of betalains from the prickle pear in an in vitro model of endothelial
cells. Here we show the capacity of betalains to protect endothelium from cy-
tokine-induced redox state alteration, through ICAM-1 inhibition.
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INTRODUCTION
Molecules of plant origin have been very much used in medicine, and new phyto-
chemicals are continuously being examined for potential pharmacological applica-
tions. Contained in some families of the caryophyllales, including red beet and
cactus pear, the betalain pigments are betalamic acid derivatives. We distinguish be-
tacyanins as conjugates of betalamic acid with 3,4-dihydroxyphenilalanine (DOPA),
which may or may not be glycosylated, and betaxanthins, conjugated with amino
acid residues. The red betanin (the adduct contains 5-O-glucose cyclo-DOPA) and
the yellow indicaxanthin (the adduct contains proline) have recently been isolated
from cactus pear (Opuntia ficus-indica) and characterized by our group. Both com-
pounds are able to quench the 2,2′-azino-bis(3-ethylbenz-thiazoline-6-sulfonic acid)
(ABTS) cation radical.1 More important, protective antioxidant effects of betalains
have been shown in a number of in vitro models.2,3 In particular, we have demon-
strated that betanin and indicaxanthin may bind to human low-density lipoproteins
(LDLS),3 inhibiting their oxidation. Last, the synergistic interaction with the LDL-
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vitamin E appears to add a remarkable potential in indicaxanthin to scavenge lipop-
eroxyl radicals.3
Reactive oxygen or nitrogen species (ROS/RNS) may be toxic or display a regu-
latory character. The redox status of cells is continuously surveyed by antioxidant
molecules and enzymes in order to avoid damage to cell components, as well as to
regulate redox-mediated signaling pathways involved in cell growth, senescence,
and death. This kind of regulation is also at work during the inflammatory reaction,
originating in the activation of vascular endothelial cells.4 Moreover, in acute and
chronic inflammatory diseases, such as ischemia-reperfusion injury, rheumatoid ar-
thritis, or inflammatory bowel disease, the oxidant tone is also responsible for en-
dothelial dysfunction.5 Moreover, ROS-generated endothelial dysfunction appears
to be crucial in the pathogenesis of atherosclerosis, as well as a relevant support for
cancer dissemination.6 Hence, endothelium seems to be an ideal target for anti-
inflammatory molecules. We have shown that betalains are potent radical scaven-
gers in chemical systems and behave as efficient antioxidants in a number of
biological models.1,2
Cell-adhesion molecules of the Ig-superfamily7 are characteristically expressed
by vascular endothelial cells in response to proinflammatory stimuli. Their mem-
brane expression is devoted to the recruitment of activated leukocytes, finalized to
surveying of tissue or defense from microorganisms. Vascular endothelium express-
es the constitutive form of intercellular adhesion molecule-1 (ICAM-1), present in
all cell types with the exception of red blood cells. Its expression is greatly enhanced
by the stimulation of endothelial cells by tumour necrosis factor-α (TNF-α) a major
cytokine that is pivotal in the inflammatory reaction as well as in a plethora of other
functions.8 The mechanism of action of TNF-α has been shown to depend on the
FIGURE 1. Signal transduction pathways of cell adhesion molecule expression.
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production of ROS through the activation of at least two transcription factors, NF-
κB, and AP-1 (FIG. 1). In this work, human primary endothelial cells, isolated from
umbilical cords, are stimulated by TNF-α, and the two antioxidant molecules
betanin and indicaxanthin are tested for their capacity to inhibit the expression of
ICAM-1. 
MATERIALS AND METHODS
Cell cultures. Human umbilical vein endothelial cells (HUVECs) were isolated
after collagenase digestion of human umbilical cord veins collected from healthy,
nonsmoking women. Umbilical cords were collected with the patients’ informed
consent. Cells were cultured in endothelial cell basal medium MV2 (ECBM MV2,
PromoCell), supplemented with epidermal growth factor (50 ng/mL), hydrocorti-
sone (0.2 µg/mL), vascular endothelial growth factor (5.0 ng/mL), basic fibroblast
factor (10 ng/mL), R3IGF-1 (20 ng/mL), ascorbic acid (1 µg/mL), amphotericin B
(50 ng/mL), gentamycin (50 µg/mL), and fetal calf serum (10%). HUVEC were sub-
cultured by trypsinization (Trypsin-EDTA, Sigma) and used for the investigation up
to passage 6. Cell incubations were done at 37°C in a humidified atmosphere with
5% CO2.
Betalains, antibodies, and cytokines. Betanin and indicaxanthin were purified
from fresh pulp of cactus pear (Opuntia ficus-indica), as previously described.1
TNF-α was purchased from R&D Systems. Betalains and TNF-α were dissolved in
PBS and kept at –20°C as stock solutions. Anti-human ICAM-1Fitc was obtained
from Diaclone Research and kept at 4°C.
MTT assay. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-dipheniltetrazolium bro-
mide] (Sigma) assay was used to check the viability of cells to the exposure to bet-
anin and indicaxanthin. Briefly, HUVEC were seeded in duplicate on 96-well
culture plates at 2.104 cells/cm2. After 24-h incubation, either betanin or indicaxan-
thin was delivered at various concentrations, and the incubation was continued for
24 h. Then, MTT stock solution (5 mg/mL) was added to each well, and plates were
incubated for 4 h. At the end of the incubation period, the medium was removed, and
converted dye was solubilized with DMSO. Absorbance of converted dye was mea-
sured at 550 nm with a microplate reader.
Betanin and indicaxanthin treatments. HUVEC were seeded in duplicate in 12-
well culture plates at a density of 2.104 cells/cm2 in ECBM MV2 10% FCS. After
48 h the cells were starved in serum-free medium for 8 h and then incubated with 5
µM of either betanin or indicaxanthin. The medium was removed after 5 h of incu-
bation, and the cells were incubated with 1 ng/mL TNF-α and/or 5mM betalains for
16 h. Incubation in the presence of betalains and relevant controls were done in
ECBM MV2 without ascorbic acid and FCS.
Flow cytometry analysis. After treatments, HUVECs were harvested, and flow
cytometry measurements were performed by incubation of cells with anti-human
ICAM-1 Fitc diluted 1/100 in FACS buffer (0.5% BSA in PBS). After fixation with
1% phormol in PBS, the cells were analyzed for fluorescence on a Becton Dickinson
FACSCalibur flow cytometer, and data were acquired and analyzed using FACS/
CELLQuest software (San Jose, CA) on a Power Macintosh 7600/120 computer
(Apple Computers, Cupertino, CA).
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FIGURE 2. Effect of Betalains on cell viability (A and B) and on ICAM-1 expression (C).
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RESULTS
The activity of betanin and indicaxanthin on the endothelial expression of adhe-
sive molecule ICAM-1 has been tested by incubating HUVECs with either com-
pound in the presence or absence of TNF-α. Both betalains are nontoxic within a
concentration range of 1 to 10 µM (indicaxanthin) and 1 to 50 µM (betanin) (FIG. 2
A and B). Inhibition of ICAM-1 expression is obtained at 5 µM (FIG. 2 C). Betanin
(30% inhibition, P < 0.001 with respect to control cells incubated in the absence of
betalains) was more effective than indicaxanthin (17% inhibition, P < 0.001).
DISCUSSION
During the last decades, one of the most challenging pharmacological approaches
has focused on the identification and characterization of molecules of plant origin,
integrating notions of traditional phytotherapy, biochemistry, cell biology, and syn-
thetic chemistry. In some cases, new chemical entities have emerged, such as taxol9
and resveratrol,10 which have been found to be effective in the treatment of cancer
and degenerative diseases. Betalains are reducing substrates and, as with many anti-
oxidants, could affect intracellular signal transduction. This study has investigated
the effect of betanin and indicaxanthin, known for their antioxidant effects in lipid
peroxidation, on the expression of endothelial adhesion molecules, using an in vitro
model of the inflammatory reaction. Both pigments were able to slightly inhibit the
expression of the cell-adhesion molecule ICAM-1 at a micromolar concentration.
The expression of adhesion molecules is a complex multifactorial redox-regulated
process in which the first step could be represented by an intracellular increment of
oxidants.11 It is under current investigation whether betalains could modulate, by
their radical scavenging activity, cellular ROS/RNS levels and/or the activity of the
two main redox-sensitive transcription factors NF-κB and AP-1. Our present data
demonstrate that these phytochemicals, in addition to their radical-scavenging and
antioxidant effects, can also act as modulators of adhesive molecule expression in
endothelial cells. The combination of these two properties could be of pharmacolog-
ical interest in pathologies characterized by tissue degeneration due to endothelial
dysfunction such as atherosclerosis, atherothrombosis, low limb ischemia, and
stroke.12
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